PRPO · Precipio, Inc.
$23.12
-0.07 (-0.30%)
At close · Oct 9
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Notwithstanding the aforementioned circumstances, there remains substantial doubt about the Company's ability to continue as a going concern for the next twelve months from the date these condensed consolidated financial statements were issued. There can be no assurance that the Company will be able to successfully achieve its initiatives summarized above in order to continue as a going concern over the next twelve months from the date of issuance of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 14, 2026
Market Cap
$41.51M
Shares
1.79M
Volume · Oct 9
22.2K
Avg daily vol (3M)
127.99K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$23.19
Open$23.23
Day$22.55–23.72
52W close$17.00–32.37
Avg vol 30d125K
Short int69K · 3.8% float · 1.0d
Short vol34%
Last earningsAug 17, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 14
Up next
Next earnings call
Nov 11, 2026
Est · unconfirmed
· in 5 wks
filed Aug 14, 2026
call held May 18, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$27.20M
Trailing 12 months
Net income (TTM)
−$1.22M
Trailing 12 months
Revenue growth YoY
+24.2%
Year over year
Operating margin
-5.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
1.9%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+11.5%
Year over year · more shares
Price change (1Y)
+25.5%
Trailing year
Short interest
3.8%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−8%
below
Price vs 50-day avg
−9%
below
RSI (14)
39
neutral
MACD trend
Negative
52-week position
40%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−14%
trailing
6-month return
−18%
trailing
YTD return
+1%
this year
Relative strength
−27%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $25 › 200d $25 — 50d above 200d
Institutional flow
Accumulating
+20% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.83% of float · ▼ -7.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
18 holders — mid 3-yr range
Squeeze score
47
elevated · 0–100
Fundamentals
Revenue growth
+30%
Y/Y
Gross margin
45%
expanding
EPS growth
+92%
Y/Y
Free cash flow
$359.0K
Balance sheet
$2.6M
net cash
Quant / Vol
risk profile
Volatility
66%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
6.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−8%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
39
Neutral
MACD trend
Negative
Bearish
52-week position
40%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $25 › 200d $25 — 50d above 200d
Institutional flow
Accumulating
+20% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.83% of float · ▼ -7.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
18 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $17
Now $23 · 40%
Range high $32
vs 200-day avg -8%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| cases processed | 4,652 | Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PRPO
this stock
Precipio, Inc.
|
$41.51M | +0.9% | +29.8% | — | 3.8% |
|
TMO
Thermo Fisher Scientific Inc.
|
$241.07B | +12.5% | +14.5% | 35.1 | 1.5% |
|
DHR
Danaher Corp /De/
|
$154.82B | -5.0% | +8.5% | 39.1 | 1.3% |
|
NTRA
Natera, Inc.
|
$56.33B | +70.6% | -2.8% | — | 4.4% |
|
A
Agilent Technologies, Inc.
|
$47.41B | +23.6% | +6.4% | 33.1 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PRPO | +2.0% | -13.8% | -18.1% | -2.1% | +0.9% |
| SPY | +1.3% | +2.1% | +9.0% | +1.5% | +13.5% |
| vs SPY | +0.7% | -15.9% | -27.0% | -3.6% | -12.6% |